TPO-receptor agonists in ITP: A clinician's navigation between scylla and charybdis
Platelet response as the basis for approval in chronic immune (idiopathic) thrombocytopenic purpura (ITP): A regulatory perspective
Platelet count or bleeding as the outcome in ITP trials?
Thrombopoietin receptor agonists in the treatment of immune thrombocytopenia: A clinician's perspective
Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia
A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia
Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis
Second round robin for plasma hepcidin methods: First steps toward harmonization
Bleeding and mortality outcomes in ITP clinical trials: A review of thrombopoietin mimetics data
Follicular lymphoma: 2012 update on diagnosis and management
Thrombotic thrombocytopenic purpura in a patient with hemoglobin E disease–the importance of timely examination of a blood film
Decades after the cooperative study: A re-examination of systemic blood pressure in sickle cell disease
Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma
Impact of PCA strategies on pain intensity and functional assessment measures in adults with sickle cell disease during hospitalized vaso-occlusive episodes
Development of a rapid multiplex PCR assay for identification of the three common Hemoglobin-Lepore variants (Boston-Washington, Baltimore, and Hollandia) and identification of a new Lepore variant
The effect of whole body vibration therapy on bone density in patients with thalassemia: A pilot study
Comment on: Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebo-controlled crossover 4g study and an open-label 8g extension study
Response to Vermorken et al - curcumin and free light chains
Reduced deformability of circulating erythrocytes: A marker of hyposplenism
The effect of HIF-1 and HIF-2 on the regulation of angiogenic genes in endothelial cells
Inflammation in renal EPO producing cells
Conditional PHD2 Deficiency Leads to Non-Lethal Excessive Erythrocytosis and delayed wound healing in Mice
Acute Vhl Gene Inactivation Induces Cardiac HIF-Dependent Erythropoietin Gene Expression
Role of HIF-2α in iron metabolism
Hypoxia-inducible factor regulation of hepcidin requires EPO
Regulation of iron homeostasis in mice overexpressing human erythropoietin
Vitamin C is not required for oxygen sensing in vivo
Critical importance of the region C terminal to the hydroxyacceptor proline for the regulation of HIF-2alpha
A physiological study of Tibetan natives at sea level
The Erythropoietin (Epo) Gene Polymorphism (rs16171640) in Preterm Infants with Retinopathy
EFFECT OF CHRONIC KIDNEY DISEASE (CKD) AND HEMODIALYSIS ON PROTEIN AND AMINO ACID METABOLISM
Pre-vertebrate evolution of erythropoietin signalling serving neuroprotection and neuroregeneration
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance
Erythropoietin induced neural differentiation in stem cells
Neurotrophic and neuroprotective properties of non-hematopoietic EPO-derived peptides
Metabolic activity associated with erythropoietin
The antioxidant effect of erythropoietin on thalassemic blood cells
Myocardial Na,K-ATPase and its role in Epo-induced cardioprotection
Erythropoietin (Epo) exerts an anti-neoplastic activity: characterizing Epo-driven responses in the 5T33 multiple myeloma mouse model.
Iron dynamics and erythroblast maturation kinetics after C.E.R.A. treatment
First results on regenerative effects of erythropoietin in burn and scald injures (clinical trial: “EPO in Burns”)
EPOR deficiency on glioma cells induces sensitivity to ionizing radiation and temozolomide
Pharmacokinetics, biodistribution, metabolism and excretion of peginesatide, an erythropoiesis-stimulating agent, in rats
Carbon dioxide (CO2) sensing at the axis of immunity and inflammation
Metabolic effects of acute and prolonged treatment with rHuEpo to healthy young men
Cerebral Epo and excercise performance
Detection of EPO gene doping in blood
Epigenetic regulation of hypoxia-dependent erythropoietin gene expression
Novel pointers to regulation and targets of erythropoietin in human skin: An exploratory pilot study
Erythropoietin production in neural crest cells
Perioperative Serum Erythropoietin and Thrombopoietin levels in Coronary Artery Bypass Grafting (CABG)
Nitric oxide and hypoxia stimulate and regulate erythropoietin receptor in endothelial cells
IL-4 attenuates the proangiogenic capacity of macrophages by downregulating HIF-1α protein
The Role of Hypoxia-Inducible Factors in Inflammatory Bowel Disease
Erythropoietin as a link between skin and kidney
Expression of the cellular oxygen sensor PHD2 affects radioresistance in squamous cell cancer of the head and neck
Expression of the amiloride binding protein 1 (Abp1) is stimulated in response to hypoxia and myocardial infarction
Distinct impacts of Interleukin-1β on HIF-1α and HIF-2α in tumor cells
Analysis of the erythropoietin receptor dimer in different cancer cell lines by means of Fluorescence Resonance Energy Transfer
Erythropoietin drives neurodifferentiation
Epo regulates hypoxic signal transduction in rat carotid body glomus cells via potassium channel remodelling
Enteral Erythropoietin & Iron Transporter Expression in Newborn Rats
Erythropoietin promotes survival and regeneration of insect neurons in vivo and in vitro
CHARACTERIZATION OF THE ERYTHROPOIETIN/ERYTHROPOIETIN RECEPTOR AXIS IN A RAT MODEL OF LIVER DAMAGE AND CHOLANGIOCARCINOMA DEVELOPMENT
Influence of erythropoietin on survival and neuronal differentiation of mouse induced pluripotent stem cells
Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice
A novel mimetic of erythropoietin for the treatment of Alzheimer's disease-like pathology
Erythropoietin modulates breast cancer cell response to cisplatin in a time-dependent manner
Screening for ER proteins that influence folding and cell surface exposure of the erythropoietin receptor
Characterization of dendritic cells under inflammatory hypoxia
Growth factor in PRP - general approaches - a review of recent developments
Specific and sensitive immunohistochemistry detection of the human erythropoietin receptor in situ
Erythropoietin (EPO) stimulates aerobic and anaerobic processes in rat cardiomyocytes
Effects of nitric oxide on hematogenous metastasis
Modulation of oxygen sensing by nitric oxide in an autochthonous mouse model of breast cancer
WHY RECOMBINANT ERYTHROPOIETIN THERAPY IS VERY EFFECTIVE FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PREGNANCY?
Semisynthesis of human Erythropoietin glycosylated at Asn24
Novel Erythropoietin-Receptor peptide antagonists
RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY OF ANEMIC PATIENTS WITH LUNG TUBERCULOSIS
EPO-Independent Functional EPO Receptor in Breast Cancer Enhances Estrogen Receptor Activity and Promotes Cell Proliferation
PREOPERATIVE USE OF RECOMBINANT HUMAN ERYTHROPOIETIN FOR PREVENTION OF BLOOD TRANSFUSIONS IN PULMONARY TUBERCULOSIS PATIENTS
Serum erythropoietin, plasma volume regulating hormones, and plasma volume changes induced by exercise and thermal dehydration
Epo and EpoR signaling dynamic in hematopoietic and tumor context
Effects of HIF stabilizers in isolated perfused rat kidneys: implications for blood doping